- Home
- A-Z Publications
- Current Drug Delivery
- Previous Issues
- Volume 15, Issue 6, 2018
Current Drug Delivery - Volume 15, Issue 6, 2018
Volume 15, Issue 6, 2018
-
-
Recent Approaches in the Development of Phytolipid Complexes as Novel Drug Delivery
Authors: Nandkishor S. Talware, Remeth J. Dias and Vankadari R. GuptaThe imbalance of hydrophilicity and lipophilicity along with a large molecular size (due to a unique chemical structure) of natural compounds or plant actives poses a significant challenge for their absorption through a biological membrane and thus, alters the therapeutic efficacy. Therefore, it is desirable to have a novel approach for such formulation in order to improve the solubility and bioavailability of these phytoconstituent Read More
-
-
-
Confronting Penetration Threshold via Fluidic Terpenoid Nanovesicles
Authors: Kamla Pathak, Ankur Vaidya and Vijay SharmaBackground: Improvisation of the nanosized vesicular systems has led to a series of useful developments including the deformable vesicles namely transfersomes, ethosomes and invasomes. The former two have been explored extensively, however, literature on invasomes is relatively scanty. Method: Invasomal formulations researched for various applications have been reviewed using search engine “Scopus”. The present rev Read More
-
-
-
Insulin Therapy for Diabetes Epidemic: A Patent Review
Authors: Runjhun Tandon, Vijay Luxami, Harmanjit S. Dosanjh, Nitin Tandon and Kamaldeep PaulDiabetes is a serious and chronic problem that can be attributed to the insufficient release of the insulin or when body does not respond to the insulin which is already present. This disease has been targeted for corrective action and implementation among four non-communicable diseases by world leaders according to WHO report. The prevalence of diabetes has been estimated to be double from 4.7% of adult population i Read More
-
-
-
Ethosomes as Novel Vesicular Carrier: An Overview of the Principle, Preparation and its Applications
Background: In the study of lipid vesicular carriers in permeation enhancement of drug molecules across skin after the success story of liposomes, ethosomes are a recent addition. There are a number of published reviews but still, there is a lack of reviews representing various aspects in a systematic way with a detailed description of current research works. This review serves to fill this deficiency along with special emphasi Read More
-
-
-
Solid Lipid Nanoparticles Approach for Lymphatic Targeting through Intraduodenal Delivery of Quetiapine Fumarate
Authors: Mohd Yasir, Praveen K. Gaur, Dinesh Puri, Preeti Shehkar and Shanmugam Sadish KumarBackground: Lymphatic route is one of the prominent routes for improving the poor bioavailability of the drugs which undergo extensive hepatic first pass metabolism. Nanocarriers (solid lipid nanoparticles) offer a new drug delivery system that could hold great promise for attaining the bioavailability enhancement along with controlled and site specific drug delivery. Objective: The aim of the present research work was to Read More
-
-
-
Fabrication and Characterization of Timolol Maleate and Brinzolamide Loaded Nanostructured Lipid Carrier System for Ocular Drug Delivery
Authors: Nupur Shrivastava, Saba Khan, Sanjula Baboota and Javed AliBackground: The combination of timolol maleate (TM) and brinzolamide (BRZ) has potential therapeutic prospects for treating glaucoma. However, the conventional formulation of TM and BRZ exhibits sub optimal therapeutic effects attributable to the poor ocular bioavailability of these drugs. Objective: Therefore, the aim of the present study was to design and evaluate TM and BRZ loaded nanostructured lipid carrier (NLC) to Read More
-
-
-
Arginine Functionalized Bacterial Cellulose Nanofibers Containing Gel as an Effective Wound Dressing: In vitro and In vivo Evaluation
Authors: Farideh Feizabadi, Mohsen Minaiyan and Azade TaheriBackground: Nanofibers such as bacterial cellulose nanofibers (BC-NFs) have gained increasing attention for use in wound dressings. Topical application of arginine can stimulate wound healing significantly. Objective: In order to promote the wound healing process, arginine functionalized BC-NFs containing gel (Arg-BC-NFs gel) was prepared by the electrostatic attachment of arginine on the surface of BCNFs. Method: The Read More
-
-
-
Silver Nanoparticles with High Loading Capacity of Amphotericin B: Characterization, Bactericidal and Antifungal Effects
Authors: Victoria Leonhard, Roxana V. Alasino, Adrian Munoz and Dante M. BeltramoThe purpose of this study was to evaluate the most appropriate conditions to generate silver nanoparticles (AgNPs) loaded with a potent antimycotic drug like amphotericin B (AmB), characterize the physicochemical properties, and to evaluate the cytotoxic effect and biological activity of these new nanostructures as a potential nanocarrier for hydrophobic drugs. It was determined that the optimal molar ratio between Read More
-
-
-
Antifungal Activity of Eugenol Loaded Electrospun PAN Nanofiber Mats Against Candida Albicans
Background: Eugenol, as the major phenolic component of clove essential oil due to its desired properties in medical field, was loaded into polyacrylonitrile (PAN) nanofibers with various percentages. Objective: Our main purpose in this study was to determine the in vitro antifungal activity of eugenol loaded on PAN nanofibers against Candida albicans as the most common causative agent for candidiasis. Method: Als Read More
-
-
-
Insights into the Influences of Carboxymethyl-β-Cyclodextrin on DNA Formulations Characteristics and Gene Transfection Efficiency
Authors: Hassan Elsana, Svetlana Mysina, Eman A. Elkordy, Jane Carr-wilkinson and Amal Ali ElkordyBackground: Gene therapy is an expanding field and it can treat genetic and acquired diseases. Objective: It was found that formulations with DNA: CM-β–CD (Carboxymethyl-beta-cyclodextrin): Pluronic-F127 1:3:3 and 1:3 DNA: CM-β–CD are the most stable formulations indicating high incorporation of DNA within CM-β –CD. Method: Gel electrophoresis revealed DNA with low CM-β –CD concentration has formed a more s Read More
-
-
-
Silk Fibroin Improves the Release of Nerve Growth Factor from Hydroxyapatite Particles Maintaining its Bioactivity
Authors: Xue Han, Hongzhuo Liu, Xiao Kuang, Zhenjie Wang and Xinyu WangBackground: Hydroxyapatite (HA) was emerging as the most promising biomaterial owing to its excellent bioactivity, biocompatibility, and high compressive strength for segmental bone defects. However, due to the lack of synergistic signals of osteogenic cells or growth factors, attempts concerning HA have not achieved an ideal therapeutical effect. Objective: This work was intended to combine HA particles with nerve gr Read More
-
-
-
Formulation and Investigation of a Lipid Based Delivery System Containing Antimicrobials for the Treatment of Periodontal Disease
Authors: Attila Leber, Maria Budai-Szucs, Edit Urban, Peter Valyi, Anita Kovacs, Szilvia Berko and Erzsebet CsanyiBackground: Periodontitis is a chronic inflammatory disease, which affects the supporting tissues of the teeth, and without proper treatment it may lead to tooth loss. Antibiotics - administered orally - have been widely used in the treatment of periodontitis. With the conventional administration routes, adequate drug levels cannot be reached in the periodontal pockets and oral application of antimicrobials could lead to side effec Read More
-
-
-
Brain Targeted Intranasal Zaleplon Nano-Emulsion: In-Vitro Characterization and Assessment of Gamma Aminobutyric Acid Levels in Rabbits' Brain and Plasma at Low and High Doses
Authors: Eman Abd-Elrasheed, Sara N. El-Helaly, Manal M. EL-Ashmoony and Salwa SalahBackground: Zaleplon is a pyrazolopyrimidin derivative hypnotic drug indicated for the short-term management of insomnia. Zaleplon belongs to Class II drugs, according to the biopharmaceutical classification system (BCS), showing poor solubility and high permeability. It undergoes extensive first-pass hepatic metabolism after oral absorption, with only 30% of Zaleplon being systemically available. It is available in tablet form Read More
-
-
-
Enhancing the Intestinal Permeation of the Chondroprotective Nutraceuticals Glucosamine Sulphate and Chondroitin Sulphate Using Conventional and Modified Liposomes
Authors: Ahmed M. Agiba, Maha Nasr, Sameh Abdel-Hamid, Ahmed B. Eldin and Ahmed S. GeneidiBackground: Liposomes are promising systems for the delivery of macromolecules and poorly absorbed drugs, owing to their ability to compartmentalize drugs, their biodegradability and biocompatibility. Objective: The aim of the present study was to formulate and evaluate conventional and modified glucosamine sulphate (GluS) and chondroitin sulphate (CS) liposomal formulations, to enhance their oral per Read More
-
Volumes & issues
-
Volume 22 (2025)
-
Volume 21 (2024)
-
Volume 20 (2023)
-
Volume 19 (2022)
-
Volume 18 (2021)
-
Volume 17 (2020)
-
Volume 16 (2019)
-
Volume 15 (2018)
-
Volume 14 (2017)
-
Volume 13 (2016)
-
Volume 12 (2015)
-
Volume 11 (2014)
-
Volume 10 (2013)
-
Volume 9 (2012)
-
Volume 8 (2011)
-
Volume 7 (2010)
-
Volume 6 (2009)
-
Volume 5 (2008)
-
Volume 4 (2007)
-
Volume 3 (2006)
-
Volume 2 (2005)
-
Volume 1 (2004)
Most Read This Month
Article
content/journals/cdd
Journal
10
5
false
en

Most Cited Most Cited RSS feed
-
-
Preface
Authors: Deng-Guang Yu and He Lv
-
- More Less